VICTORY SQUARE TECH ORD - VSQTF STOCK NEWS

Victory Square Technologies announced that its portfolio company, Hydreight Technologies, has added Tirzepatide to its weight loss portfolio. Tirzepatide, an FDA-approved medication for type 2 diabetes, is also effective for weight loss and will be available through Hydreight's platform across 700 cities in the US. This addition complements their existing GLP-1 injections, including Semaglutide, which saw a 250% increase in orders between January and February 2024. Hydreight's growing network includes over 3,000 nurses and 107 white-label locations. In 2023, Hydreight reported a 102% revenue increase, reaching $17.05 million. This expansion aligns with the projected growth in the anti-obesity market, which could reach $100 billion by 2030.

Victory Square Technologies reported revenue growth from $5.9M in 2022 to $12M in 2023, with a gross margin increase to $5.49M. Cash and liquid securities stand at $4.9M. Key portfolio updates include Hydreight’s 102% revenue growth, GameOn’s $9.3M deal with Sportsology, and XR Immersive’s expansion with over 500 VR operators. Covalent’s market cap rose 28% QoQ, while FansUnite generated $23.72M in revenue for 2023. Notable transactions include Turnium’s LOI to acquire Claratti and Stardust Solar’s acquisition proposal by BOLD TSX.V valued at $15.4M. Victory Square will host an investor webinar on May 23, 2024.

Victory Square Technologies reported its 2023 financial results, showcasing a diverse portfolio of 25+ innovative companies in sectors like Digital Health, AI, ML, Blockchain, VR/AR, Gaming, and Climate Tech. With revenue reaching $12,055,070, a significant increase from the previous year, the company also holds cash & liquid securities of approximately $4,903,363. Victory Square's business model focuses on buying, building, and investing in early-stage tech companies, with substantial involvement from its management team and advisors. The company aims to drive value by monetizing investments and reinvesting gains in new innovations. Despite a net loss primarily due to fair value write-downs on portfolio investments and operating losses, Victory Square remains optimistic about its continued growth in 2024.

Victory Square Technologies Inc. announces a corporate update from its portfolio company Stardust Solar Technologies Inc. The company reported a 50% YOY revenue growth in 2023, surpassing its $3M revenue goal by 10%. Stardust Solar also achieved over 100% growth in product sales & royalties, 80% growth in system-wide sales in Canada, and over 200% increase in U.S. franchise company revenues. The company now has 31 franchise territories in North America and achieved NABCEP accreditation for its PV technical sales training and is developing new accreditations for PV installation professional and energy storage system installation training.

Victory Square Technologies Inc. (VST) provides access to a portfolio of entrepreneurs and innovations. Its portfolio company XR Immersive Tech Inc. (VRAI) is a leader in Social Entertainment, AI, VR, and AR content. The business update includes a focus on the Synthesis VR software platform, key achievements, and the VR landscape.

Victory Square Technologies Inc. (VST) Announces Year-End Review and 2024 Outlook for Portfolio Company Hydreight Technologies Inc. (NURS)

Victory Square Technologies Inc. (VST) announces Hydreight's integration of Semaglutide injections for at-home medical services, targeting the growing global anti-obesity medication market.

Victory Square Technologies Inc. (VST) experienced a significant revenue increase for the nine-month period ended September 30, 2023, reaching $8,729,248 compared to $3,852,101 for the same period last year. The company holds cash and liquid securities of approximately $5,255,400.22. Victory Square is a Venture Builder with a diverse portfolio of 25+ innovative companies from around the world, covering sectors such as Digital Health, AI, ML, Blockchain, VR/AR, Gaming, and Climate Tech. The company follows a business model that involves buying, building, and investing in early-stage tech companies, driving value by monetizing investments and reinvesting the gains in new innovations.

Victory Square Technologies Inc. (CSE:VST) (OTC:VSQTF) (FWB:6F6) announces that portfolio company Hydreight Technologies Inc. (TSXV: NURS)(OTCQB: HYDTF)(FSE: SO6) received a Companies-to-Watch award as part of the 2023 Deloitte Technology Fast 50™ program. Hydreight is a fast-growing mobile clinical network and medical platform with significant organic revenue growth of 250% YoY, enabling flexible at-home medical services across 50 states in the United States. The award recognizes emerging companies based on their revenue growth percentage.